Showing results (241-250 of 3,148) with videos related to
Sort By:
Pageof 315
Neuro-Oncology|August 2, 2005
Increased efficacy of an interleukin-12-secreting herpes simplex virus in a syngeneic intracranial murine glioma modelElizabeth K Hellums, James M Markert, Jacqueline N Parker, et al.Neuro-Oncology|July 29, 2004
Brain cancer mortality in the United States, 1986 to 1995: a geographic analysisZixing Fang, Martin Kulldorff, David I GregorioNeuro-Oncology|July 29, 2004
Induction of membrane-type-1 matrix metalloproteinase by epidermal growth factor-mediated signaling in gliomasTimothy E Van Meter, William C Broaddus, Harcharan K Rooprai, et al.Neuro-Oncology|July 29, 2004
Intercellular heterogeneity of expression of the MGMT DNA repair gene in pediatric medulloblastomaBrian R Rood, Huizhen Zhang, Philip H CogenNeuro-Oncology|July 29, 2004
Phase 1 study of 28-day, low-dose temozolomide and BCNU in the treatment of malignant gliomas after radiation therapyJeffrey J Raizer, Mark G Malkin, Martin Kleber, et al.Neuro-Oncology|April 16, 2005
Endogenous inhibitors of angiogenesis in malignant gliomas: nature's antiangiogenic therapyTanya A Rege, Constance Y Fears, Candece L GladsonNeuro-Oncology|April 16, 2005
Functional comparison of long and short splice forms of RPTPbeta: implications for glioblastoma treatmentGustavo Lorente, April Nelson, Sabine Mueller, et al.Neuro-Oncology|April 16, 2005
Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiformeCaterina Giannini, Jann N Sarkaria, Atsushi Saito, et al.Neuro-Oncology|April 16, 2005
Oral sodium phenylbutyrate in patients with recurrent malignant gliomas: a dose escalation and pharmacologic studySurasak Phuphanich, Sharyn D Baker, Stuart A Grossman, et al.Neuro-Oncology|April 16, 2005
Cost of temozolomide therapy and global care for recurrent malignant gliomas followed until deathJean-Blaise Wasserfallen, Sandrine Ostermann, Serge Leyvraz, et al.Pageof 315